Abstract
Since the previous review,1 there has been considerable growth in interest in the ectopic hormone syndromes. Both radioimmunoassays and radioreceptor assays have been applied much more widely to extracts of the serum and tumors of patients with malignant disease. As a result, there has been widespread recognition of polypeptide hormones in tissues far in excess of that previously observed.2–6 Even more intriguing has been the recognition of peptide hormones in normal nonendocrine tissues such as liver and colon7 and in steroid-producing tissues such as the testis8 (see Table I). These fascinating observations have challenged classic concepts of pathogenesis and have led to considerable speculation concerning the nature of these disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sherwood, L.M., 1976, Ectopic hormone syndromes, in: The Year in Endocrinology 1975–1976 (S.H. Ingbar, ed.), pp. 249–276, Plenum Medical Book Company, New York.
Gewirtz, G., and Yalow, R.S., 1974, Ectopic ACTH production in carcinoma of the lung, J. Clin. Invest. 53: 1022–1032.
Odell, W., Wolfsen, A., Yoshimoto, Y., Weitzman, R., Fisher, D., and Hirose, F., 1977, Ectopic peptide synthesis: A universal concomitant of neoplasia, Trans. Assoc. Am. Physicians 90: 204–227.
Ghosh, N.K., and Cox, R.P., 1976, Production of human chorionic gonadotropins in HeLa cell cultures, Nature (London) 259: 416–417.
Lieblich, J.M., Weintraub, B.D., Rosen, S.W., Chou, J.Y., and Robinson, J.C., 1976, HeLa cells that produce α subunit of glycoprotein tropic hormones, Nature (London) 260: 530–532.
Rosen, S.W., Weintraub, B.D., and Aaronson, S., 1978, Nonrandom ectopic protein production by malignant cell lines: Direct evidence in vitro, Clin. Res. 26: 537a.
Yoshimoto, Y., Wolfsen, A.R., and Odell, W.D., 1977, Human chorionic gonadotropin-like substance in nonendocrine tissues of normal subjects, Science 197: 575–577.
Braunstein, G.D., Rasor, J., and Wade, M.E., 1975, Presence in normal human testes of a chorionic gonadotropin-like substance distinct from human luteinizing hormone, N. Engl. J. Med. 293: 1339–1343.
Pearse, A.G.E., 1969, The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept, J. Histochem. Cytochem. 17: 303–313.
Sherwood, L.M., and Gould, V.E., 1978, Ectopic hormone syndromes and multiple endocrine neoplasia, in: Metabolic Basis of Endocrinology (L. DeGroot, ed.), pp. 1749–1788, Grune and Stratton, New York.
Pictet, R.L., Rall, L.B., Phelp, P., and Rutter, W., 1976, The neural crest and the origin of the insulin-producing and other gastrointestinal hormone-producing cells, Science 191: 191–192.
Levine, R.J., and Metz, S.A., 1974, A classification of ectopic hormone-producing tumors, Ann. N.Y. Acad. Sci. 230: 533–546.
Pearse, A.G.E., and Polak, J.M., 1974, Endocrine tumours of neural crest origin: Neurolophomas, apudomas and the APUD concept, Med. Biol. 52: 3–18.
Smith, L.H., 1975, Oat cell carcinoma as a malignant apudoma, J. Thorac. Cardiovasc. Surg. 70: 147–151.
Pearse, A.G.E., 1975, Neurocristopathy, neuroendocrine pathology and the APUD concept, Z. Krebsforsch. Klin. Onkol. 84: 1–18.
Rees, L.H., Bloomfield, G.A., Rees, G.M., Corrin, B., Franks, L.M., and Ratcliffe, J.G., 1974, Multiple hormones in a bronchial tumor, J. Clin. Endocrinol. Metab. 38: 1090–1097.
Pearse, A.G.E., Polak, J.M., and Heath, C.M., 1974, Polypeptide hormone production by “carcinoid” apudomas and their relevant cytochemistry, Virchows Arch. B 16: 95–109.
Polak, J.M., Pearse, A.G.E., and Heath, C.M., 1975, Complete identification of the endocrine cells of the gastrointestinal tract using semithinthin sections to identify molitin cells in human and animal intestine, Gut 16: 225–299.
Tischler, A.S., Dichter, M.A., Biales, B., and Greene, L.A., 1977, Neuroendocrine neoplasms and their cells of origin, N. Engl. J. Med. 296: 919–925.
Tischler, A.S., Dichter, M.A., Biales, B., DeLellis, R.A., and Wolfe, H., 1976, Neural properties of cultured human endocrine tumor cells of proposed neural crest origin, Science 192: 902–904.
Andrew, A., 1976, Apud cells, apudomas and the neural crest, S. Afr. Med. J. 50: 890–898.
Weichert, R.F., III, 1970, The neural ectodermal origin of the peptide secreting endocrine cells, Am. J. Med. 49: 232–241.
Lernmark, A., Chan, S.J., Choy, R., Nathans, A., Carroll, R., Tager, H.S., Rubenstein, A.H., Swift, H.H., and Steiner, D.F., 1976, Biosynthesis of insulin and glucagon: A view of the current state of the art, in: Polypeptide Hormones: Molecular and Cellular Aspects, Ciba Found. Symp. 41: 7–30, Elsevier/Excerpta Medica, North Holland.
Habener, J.F., 1976, New concepts in the formation, regulation of release, and metabolism of parathyroid hormone, in: Polypeptide Hormones: Molecular and Cellular Aspects, Ciba Found. Symp. 41: 197–224, Elsevier/Excerpta Medica, North Holland.
Habener, J.F., Kronenberg, H., Rich, A., and Potts, J.T., Jr., 1978, Molecular mechanisms in the cellular synthesis and transport of parathyroid hormone, in: Endocrinology of Calcium Metabolism (D.H. Copp and R.V. Talmage, eds.), pp. 281–290, Excerpta Medica, Amsterdam.
Schechter, I., McKean, D.J., Gyer, R., and Terry, W., 1975, Partial amino acid sequence of the precursor of immunoglobulin light chain programmed by messenger RNA in vitro, Science 188: 160–162.
Blobel, G., and Dobberstein, B., 1975, Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma, J. Cell Biol. 67: 835–851.
Blobel, G., and Dobberstein, B., 1975, Transfer of proteins across membranes. II. Reconstitution of functional rough microsomes from heterologous components, J. Cell Biol. 67: 852–862.
Rubenstein, A.H., Mako, M.E., Starr, J.I., Juhn, D.J., and Horwitz, D.L., 1974, Circulating proinsulin in patients with islet cell tumors, in: Diabetes, Proceedings of the 8th Congress of the International Diabetes Foundation (W.J. Malaisse and J. Pirart, eds.), pp 736–762, Excerpta Medica, Amsterdam.
Yalow, R.S., and Berson, S.A., 1973, Characteristics of “big ACTH” in human plasma and pituitary extracts, J. Clin. Endocrinol. Metab. 36: 415–423.
Lips, C.J.M., Van Der Sluys Veer, J., Van Der Donk, J.A., Van Dam, R.H., and Hackeng, W.H.L., 1978, Common precursor molecule as origin for the ectopic hormone-producing-tumor syndrome, Lancet 1: 16–18.
Gewirtz, G., Snyder, B., Krieger, D.T., and Yalow, R.S., 1974, Big ACTH: Conversion to biologically active ACTH by trypsin, J. Clin. Endocrinol. Metab. 38: 227–230.
Sussman, H.H., Weintraub, E.D., and Rosen, S.W., 1974, Relationship of ectopic placental alkaline phosphatase to ectopic chorionic gonadotropin and placental lactogen, Cancer 33: 820–823.
Baylin, S.B., Weisburger, W.R., Eggleston, J.C., Mendelsohn, G., Beaven, M.A., Abeloff, M.D., and Ettinger, D.S., 1978, Variable content of histaminase l-dopa decarboxylase and calcitonin in small cell carcinoma of the lung, N. Engl. J. Med. 299: 105–110.
Hirai, H., and Alpert, E. (eds.), 1975, Carcinofetal proteins: Biology and chemistry, Ann. N.Y. Acad. Sci. 259: 1–452.
Hall T.C. (ed.), 1974, Paraneoplastic syndromes, Ann. N.Y. Acad. Sci. 230: 1–577.
Weiss, R.B., 1977, Small cell carcinoma: The “different” type of lung cancer, Geriatrics (April) 32: 75–79.
Rudman, D., Chawla, R.K., Hendrickson, L.J., Vogler, W.R., and Sophianopoulos, A.J., 1976, Isolation of a novel glycoprotein (EDC1) from the urine of a patient with acute myelocytic leukemia, Cancer Res. 36: 1837–1846.
Rudman, D., Chawla, R.K., Heymsfield, S.B., Bethel, R.A., Shoji, M., Vogler, W.R., and Nixon, D.W., 1977, Urinary excretion of the cancer-related glycoprotein EDC1: Effect of chemotherapy, Ann. Intern. Med. 86: 174–179.
Amatruda, T.T., Jr., 1974, Nonendocrine secreting tumors, in: Duncan’s Diseases of Metabolism (P.K. Bondvy and L.E. Rosenberg, eds.), pp. 1629–1650, W.B. Saunders, Philadelphia.
Amatruda, T.T., Jr., and Upton, G.V., 1974, Hyperadrenocorticism and ACTH-releasing factor, Ann. N.Y. Acad. Sci. 230: 168–180.
Rees, L.H., 1975, The biosynthesis of hormones by non-endocrine tumours—A review, J. Endocrinol. 67: 143–175.
Ratcliffe, J.G., Knight, R.A., Desser, G.M., Landon, J., and Stansfeld, A.G., 1972, Tumour and plasma ACTH concentrations in patients with and without the ectopic ACTH syndrome, Clin. Endocrinol. 1: 27–44.
Phifer, R.F., Orth, D.N., and Spicer, S.S., 1974, Specific demonstration of the human hypophyseal adrenocorticotrophic-melantrophic (ACTH/MSH) cell, J. Clin. Endocrinol. Metab. 39: 684–692.
Mains, R.E., and Eipper, B.A., 1976, Biosynthesis of the adrenocorticotropic hormone in mouse pituitary tumor cells, J. Biol. Chem. 251: 4115–4120.
Eipper, B.A., Mains, R.E., and Guenzi, D., 1976, Higher molecular weight forms of adrenocorticotropic hormone are glycoproteins, J. Biol. Chem. 251: 4121–4126.
Roberts, J.L., and Herbert, E., 1977, Characterization of a common precursor to corticotropin and β-lipotropin: Cell free synthesis of the precursor and identification of corticotropin peptides in the molecule, Proc. Natl. Acad. Sci. U.S.A. 74: 4826–4830.
Roberts, J.L., and Herbert, E., 1977, Characterization of a common precursor to corticotropin and β-lipotropin: Identification of β-lipotropin peptides and their arrangement relative to corticotropin in the precursor synthesized in a cell-free system, Proc. Natl. Acad. Sci. U.S.A. 74: 5300–5304.
Roberts, J.L., Phillips, M., Seeburg, P.H., Shine, J., Goodman, H.M., Baxter, J.D., and Herbert, E., 1978, A common precursor to ACTH and β-endorphin: Hormonal control, structure, processing and purification of structural gene fragments, Clin. Res. 26: 494a.
Orth, D.N., and Nicholson, W.E., 1977, Higher molecular weight forms of human ACTH are glycoproteins, J. Clin. Endocrinol. Metab. 44: 214–217.
Orth, D.N., 1973, Establishment of human malignant melanoma cell lines that secrete ectopic adrenocorticotropin, Nature (London) New. Biol. 242: 26–28.
Bertagna, X.Y., Nicholson, W.E., Sorenson, G.D., Pettengill, O.F., and Orth, D.N., 1978, Endorphin (END), corticotropin (ACTH) and lipotropin (LPH) production by human nonpituitary tumor in tissue culture: Evidence for a common precursor, Clin. Res. 25: 4089a.
Hirata, Y., Matsukura, S., Imura, H., Nakamura, M., and Tanaka, A., 1976, Size heterogeneity of beta MSH in ectopic ACTH-producing tumors: Presence of β-LPH-like peptide, J. Clin. Endocrinol. Metab. 42: 33–40
Bloomfield, G.A., Scott, A.T., Lowry, P.J., Gilkes, J.J.H., and Rees, L.H., 1974, The reappraisal of human β MSH, Nature (London) 252: 492–493.
Gilkes, J.J.H., Bloomfield, G.A., Scott, A.T., Lowry, P.J., Ratcliffe, J.G., Landon, J., and Rees, L.H., 1975, Development and validation of a radioimmunoassay for peptides related to β-melanocyte-stimulating hormone in human plasma: The lipotropins, J. Clin. Endocrinol. Metab. 40: 450–457.
Bachelot, I., Wolfsen, A.R., and Odell, W.D., 1977, Pituitary and plasma lipotropins: Demonstration of the artifactual nature of β MSH, J. Clin. Endocrinol. Metab. 44: 939–946.
Lazarus, L.H., Ling, N., and Guillemin, R., 1976, β-lipotropin as a prohormone for the morphinomimetic peptides, endorphins and enkephalins, Proc. Natl Acad. Sci. U.S.A. 73: 2156–2159.
Himsworth, R.L., Bloomfield, G.A., Coombes, R.C., Ellison, M., Gilkes, J.J.H., Lowry, P.J., Setchell, K.D.R., Slavin, G., and Rees, L.H., 1977, Big ACTH and calcitonin in ectopic hormone secreting tumor of the liver, Clin. Endocrinol. 7: 45–62.
Hillyard, C.J., Coombes, R.C., Greenberg, P.B., Galante, L.S., and MacIntyre, I., 1976, Calcitonin in breast and lung cancer, Clin. Endocrinol. 5: 1–8.
Garroway, N.W., Orth, D.N., and Harrison, R.W., 1976, Binding of cytosol receptor-glucocorticoid complexes by isolated nuclei of glucorticoid responsive and nonresponsive cultured cells, Endocrinology 98: 1092–1100.
Upton, G.V., and Amatruda, T.T., 1971, Evidence for the presence of peptides with corticotropin-releasing-factor-like activity in the ectopic ACTH syndrome, N. Engl. J. Med. 285: 419–424.
Yamamoto, H., Hirata, Y., Matsukura, S., Imura, H., Nakamura, M., and Tanaka, A., 1976, Studies on ectopic ACTH-producing tumors. IV CRF-like activity in tumor tissue, Acta Endocrinol. 82: 183–192.
Rees, L.H., 1977, ACTH, lipotrophin and MSH in health and disease, J. Clin. Endocrinol. Metab. 6: 137–153.
Corrigan, D.F., Schaff, M., Whaley, R.A., Czerwinski, C.L., and Earll, J.M., 1977, Selective venous sampling of differentiated ectopic ACTH secretion from pituitary Cushing’s syndrome, N. Engl. J. Med. 296: 861–862.
Bailey, R.E., 1971, Periodic hormonogenesis: A new phenomenon. Periodicity in function of a hormone-producing tumor in man, J. Clin. Endocrinol. Metab. 2: 317–327.
Chajek, T., and Romanoff, T., 1976, Cushing syndrome with clinical edema and periodic secretion of corticosteroids, Arch. Intern. Med. 136: 441–443.
Beck, C., and Burger, H.G., 1972, Evidence of the presence of immunoreactive growth hormone in cancers of the lung and stomach, Cancer 30: 75–79.
Greenberg, P.B., Martin, T.J., Beck, C., and Burger, H.G., 1972, Synthesis and release of human growth hormone from lung carcinoma in cell culture, Lancet 1: 350–352.
Beck, C., Larkins, R.G., Martin, T.J., and Burger, H.G., 1973, Stimulation of growth hormone release from superfused rat pituitary by extracts of hypothalamus and of human lung tumors, J. Endocrinol. 59: 325–333.
Dabek, J.T., 1974, Bronchial carcinoid tumor with acromegaly in two patients, J. Clin. Endocrinol. Metab. 38: 329–333.
Sonksen, P.H., Ayres, A.B., Braimbridge, M., Corrin, B., Davies, D.R., Jeremiah, G.M., Oaten, S.W., Lowy, C., and West, T.E.T., 1976, Acromegaly caused by pulmonary carcinoid tumors, Clin. Endocrinol. 5: 503–513.
Weintraub, B.D., and Rosen, S.W., 1971, Ectopic production of human chorionic somatomammotropin by nontrophoblastic cancers, J. Clin. Endocrinol. Metab. 32: 94–101.
Muggia, F.M., Rosen, S.W., Weintraub, B.D., and Hansen, H.H., 1975, Ectopic placental proteins in nontrophoblastic tumors, Cancer 36: 1327–1337.
Sherwood, L.M., Handwerger, S., McLaurin, W.D., and Lanner, M., 1971, Amino acid sequence of human placental lactogen, Nature (London), New Biol. 233: 59–61.
Horne, C.H.W., Reid, I.N., and Milne, E.D., 1976, Prognostic significance of inappropriate production of pregnancy proteins by breast cancers, Lancet 2: 279–282.
Sheth, N.A., Suraiya, J.N., Sheth, A.R., Ranadive, K.G., and Jussawalla, D.J., 1977, Ectopic production of human placental lactogen by human breast tumors, Cancer 39: 1693–1699.
Turkington, R.W., 1971, Ectopic production of prolactin, N. Engl. J. Med. 285: 1455–1458
Rees, L.H., Bloomfield, G.A., Rees, G.M., Corrin, B., Franks, L.M., and Ratcliffe, J.G., 1974, Multiple hormones in a bronchial tumor, J. Clin. Endocrinol. Metab. 38: 1090–1097.
Pierce, J.G., Faith, M.R., Giudice, L.C., and Reeve, J.R., 1976, Structure and structure-function relationships in glycoprotein hormones, in: Polypeptide Hormones: Molecular and Cellular Aspects, Ciba Found. Symp. 41: 225–250.
Vaitukaitis, J.L., Braunstein, G.D., and Ross, G.T., 1972, A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone, Am. J. Obstet. Gynecol. 113: 751–758.
Braunstein, G.D., Vaitukaitis, J.L., Carbone, P.P., and Ross, G.T., 1973, Ectopic production of human chorionic gonadotropin by neoplasms, Ann. Intern. Med. 78: 39–45.
Vaitukaitis, J.L., Ross, G.T., Braunstein, G.D., and Rayford, P.L., 1976, Gonadotropins and their subunits: Basic and clinical studies, Recent Prog. Horm. Res. 32: 289–331.
Chen, H.C., Hodgen, G.D., Matsuura, S., Lin, J.L., Gross, E., Reichert, L.E., Birken, S., Canfield, R.E., and Ross, G.T., 1976, Evidence for gonadotropin from nonpregnant subjects that has physical, immunological and biological similarities to human chorionic gonadotropin, Proc. Natl. Acad. Sci. U.S.A. 73: 2885–2889.
VanHall, E.V., Vaitukaitis, J.L., Ross, G.T., Hickman, J.W., and Ashwell, G., 1971, Immunological and biological activity of HCG following progressive desialylation Endocrinology 88: 456–464.
Tsuruhara, T., Dufau, M.L., Hickman, J., and Catt, K.J., 1972, Biological properties of HCG after removal of terminal sialic acid and galactose residues, Endocrinology 91: 296–301.
Edmonds, M., Molitch, M., Pierce, J.G., and Odell, W.D., 1975, Secretion of alpha subunits of luteinizing hormone (LH) by the anterior pituitary, J. Clin. Endocrinol. Metab. 41: 551–555.
Edmonds, M., Molitch, M., Pierce, J., and Odell, W.D., 1975, Secretion of alpha and beta subunits of TSH by the anterior pituitary, Clin. Endocrinol. 4: 525–530.
Rosen, S.W., and Weintraub, B.D., 1974, Ectopic production of the isolated alpha subunit of the glycoprotein hormones: A quantitative marker in certain cases of cancer, N. Engl., J. Med. 290: 1441–1447.
Kahn, C.R., Rosen, S.W., Weintraub, B.D., Fajans, S.S., and Gordon, P., 1977, Ectopic production of chorionic gonadotropin and its subunits by islet-cell tumors, N. Engl. J. Med. 297: 565–569.
Kourides, I.A., Weintraub, B.D., Ridgway, E.C., and Maloof, F., 1975, Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders, J. Clin. Endocrinol. Metab. 40: 872–885.
Prentice, L.G., and Ryan, R.J., 1975, LH and its subunits in human pituitary, serum and urine, J. Clin. Endocrinol. Metab. 40: 303–312.
Weintraub, B.D., Krauth, G.H., Rosen, S.W., and Rabson, A.S., 1975, Differences between purified ectopic and normal alpha subunits of human glycoprotein hormones, J. Clin. Invest. 56: 1043–52.
Lieblich, J.M., Weintraub, B.D., Krauth, G.H., Kohler, P.O., Rabson, A.S., and Rosen, S.W., 1976, Ectopic and eutopic secretion of chorionic gonadotropin and its subunits in vitro: Comparison of clonal strains in carcinomas of the lung and placenta, J. Natl. Cancer Inst. 256: 911–917.
Weintraub, B.D., Stannard, B.S., and Rosen, S.W., 1977, Combination of ectopic and standard human glycoprotein hormone alpha and beta sub-units: Discordance of immunologie and receptor-binding activity, Endocrinology 101: 225–235.
Landefeld, T., Boguslawski, S., Corash, L., and Boime, I., 1976, The cell-free synthesis of the alpha subunit of human chorionic gonadotropin, Endocrinology 98: 1220–1227.
Kirschner, M.A., Cohen, F.B., and Jespersen, D., 1974, Estrogen production and its origin in men with gonadotropin producing neoplasms, J. Clin. Endocrinol. Metab. 39: 112–118.
Cave, W.T., and Dunn, J.T., 1976, Choriocarcinoma with hyperthyroidism: Probable identity of the thyrotropin with human chorionic gonadotropin, Ann. Intern. Med. 85: 60–63.
Morley J.E., Jacobson, R.J., Melameb, J., and Hershman, J.M., 1976, Choriocarcinoma as a cause of thyrotoxicosis, Am. J. Med. 60: 1036–1040.
Miyai, K., Tanizawa, O., Yamamoto, T., Azukizawa, M., Kawai, Y., Noguchi, M., Ishibashi, K., and Kumahara, Y., 1976, Pituitary-thyroid function in trophoblastic disease, J. Clin. Endocrinol. Metab. 42: 254–259.
Azukizawa, M., Kurtzman, G., Pekary, A.E., and Hershman, J.M., 1977, Comparison of the binding characteristics of bovine thyrotropin and human chorionic gonadotropin to thyroid plasma membrane, Endocrinology 101: 1880–1889.
Hershman, J.M., and Burrow, G.N., 1976, Lack of release of human chorionic gonadotropin by thyrotropin-releasing hormone, J. Clin. Endocrinol. Metab. 42: 970–972.
O’Donnell, J., Trokoudes, K., Silverberg, J., Row, V., and Volpe, R., 1978, Thyrotropin displacement activity of serum immunoglobulins from patients with Graves’ disease, J. Clin. Endocrinol. Metab. 46: 770–777.
George, J.M., Capen, C.C., and Phillips, A.S., 1972, Biosynthesis of vasopressin in vitro and ultrastructure of a bronchogenic carcinoma, J. Clin. Invest. 51: 141–148.
Robertson, G.L., Mahr, E.N., Athar, S., and Singha, A.T., 1973, Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma, J. Clin. Invest. 52: 2340–2352.
Padfield, P.L., Morton, J.J., Brown, J.J., Lever, A.F., Robertson, J.I.S., Wood, M., and Fox, R., 1976, Plasma arginine vasopressin in the syndrome of antidiuretic hormone excess associated with bronchogenic carcinoma, Am. J. Med. 61: 825–831.
Hirata, Y., Matsukura, S., Imura, H., Yakura, T., Ihjima, S., Nagase, E.C., and Itoh, M., 1976, Two cases of multiple-hormone producing small cell carcinoma of the lung, Cancer 38: 2575–2582.
Coscia, N., Brown, R.D., Miller, M., Tanaka, K., Nicholson, W.E., Parks, K.R., and Orth, D.N., 1977, Ectopic production of antidiuretic hormone (ADH), adrenocorticotropic hormone (ACTH) and beta-melanocyte stimulating hormone (β-MSH) by an oat cell carcinoma of the lung, Am. J. Med. 62: 303–307.
Kaye, S.B., and Ross, E.J., 1977, Inappropriate anti-diuretic hormone (ADH) secretion in association with carcinoma of the bladder, Postgrad. Med. J. 53: 274–276.
Sacks, S.A., Rhodes, D.B., Malkasian, D.R., and Rosenbloom, A.A., 1975, Prostatic carcinoma producing syndrome of inappropriate secretion of antidiuretic hormone, Urology 6: 489–492.
Cassileth, P.A., and Trotman, B.W., 1973, Inappropriate antidiuretic hormone in Hodgkin’s disease, Am. J. Med. Sci. 265: 233–235.
DeTroyer, A., and Demanet, J.C., 1976, Clinical, biological and pathogenic features of the syndrome of inappropriate secretion of antidiuretic hormone, Q.J. Med. 45: 521–31
White, M.G., and Fetner, C.D., 1975, Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with lithium carbonate, N. Engl. J. Med. 292: 390–392.
Cherrill, D.A., Stote, R.M., Birge, J.R., and Singer, I., 1975, Demeclocycline treatment in the syndrome of inappropriate antidiuretic hormone secretion, Ann. Intern. Med. 83: 654–656.
Hamilton, B.P.M., Upton, G.V., and Amatruda, T.T., Jr., 1972, Evidence of the presence of neurophysin in tumors producing the syndrome of inappropriate antidiuresis, J. Clin. Endocrinol. Metab. 35: 764–767.
Sinding, C., and Robinson, A.G., 1977, A review of neurophysins, Metabolism 26: 1335–1370.
Robinson, A.G., 1975, Isolation, assay and secretion of individual human neurophysins, J. Clin. Invest. 55: 360–367.
Megyesi, K., Kahn, C.R., Roth, J., and Gorden, P., 1974, Hypoglycemia in association with extrapancreatic tumors: Demonstration of elevated plasma NSILA-s by a new radioreceptor assay, J. Clin. Endocrinol. Metab. 38: 931–934.
Megyesi, K., Kahn, C.R., Roth, J., and Gorden, P., 1975, Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components, J. Clin. Endocrinol. Metab. 41: 475–484.
Kaufmann, U., Zapf, J., Torretti, B., and Froesch, E.R., 1977, Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo, J. Clin. Endocrinol. Metab. 44: 160–166.
Megyesi, K., Gorden, P., and Kahn, C.R., 1977, Lack of a simple relationship between endogenous growth hormone and NSILA-s related peptides, J. Clin. Endocrinol. Metab. 45: 330–338.
Franklin, R.C., Rennie, G.C., Burger, H.G., and Cameron, D.P., 1976, A bioassay for NSILA-s in individual serum samples and its relationship to somatotropin, J. Clin. Endocrinol. Metab. 43: 1164–1169.
Furlanetto, R.W., Underwood, L.E., VanWuk, J.J., and D’ercole, A.J., 1977, Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay, J. Clin. Invest. 60: 648–657.
Megyesi, K., Kahn, C.R., Roth, J., Froesch, E.R., Humbel, R.E., Zapf, J., and Neville, D.M., Jr., 1974, Insulin and non-suppressible insulin-like activity (NSILA-s): Evidence for a separate plasma membrane receptor sites, Biochem. Biophys. Res. Commun. 57: 307–315.
Rechler, M.M., Nissley, S.P., Podskalny, J.M., Moses, A.C., and Fryklund, L., 1977, Identification of a receptor for somatomedin-like polypeptides in human fibroblasts, J. Clin. Endocrinol. Metab. 44: 820–831.
Hyodo, T., Megyesi, K., Kahn, C.R., Mclean, J.P., and Friesen, H.G., 1977, Adrenalcortical carcinoma and hypoglycemia: Evidence for production of non-suppressible insulin-like activity by the tumor, J. Clin. Endocrinol. Metab. 44: 1175–1184.
Bommer, G., Alterahr, E., Kuhnau, J., Jr., and Kloppel, G., 1976, Ultrastructure of hemangiopericytoma associated with paraneoplastic hypoglycemia, Z. Krebsforsch. 85: 231–241.
Lyall, S.S., Marieb, N.J., Wise, J.K., Cornog, J.L., Neville, E.C., and Felig, P., 1975, Hyperinsulinemic hypoglycemia associated with a neurofibrosarcoma, Arch. Intern. Med. 135: 865–867.
Sherwood, L.M., O’Riordan, J.L.H., Aurbach, G.D., and Potts, J.T., Jr., 1967, Production of parathyroid hormone by nonparathyroid tumors, J. Clin. Endocrinol. Metab. 27: 140–146.
Knill-Jones, R.T., Buckle, R.M., Parsons, V., Calne, R.Y., and Williams, R., 1970, Hypercalcemia and increased parathyroid-hormone activity in primary hepatoma: Studies before and after hepatic transplantation, N. Engl. J. Med. 282: 704–708.
Hamilton, J.W., Hartman, C.R., McGregor, D.H., and Cohn, D.V., 1977, Synthesis of parathyroid hormone-like peptides by a human squamous cell carcinoma, J. Clin. Endocrinol. Metab. 45: 1023–1030.
Shaw, J.W., Oldham, S.B., Rosoff, L., Bethune, J.E., and Fichman, M.T., 1977, Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the differential diagnosis of hypercalcemia, J. Clin. Invest. 59: 14–21.
Rodman, J.S., and Sherwood, L.M., 1978, Disorders of mineral metabolism in malignancy, in: Metabolic Bone Disease, Vol. II (L.V. Aviole and S.M. Krane, eds.), pp. 577–631, Academic Press, New York.
Segre, G.V., Habener, J.F., Powell, D., Tregear, G.W., and Potts, J.T., Jr., 1972, Parathyroid hormone in human plasma: Immunochemical characterization and biological implications, J. Clin. Invest. 51: 3163–3172.
Yalow, R.S., 1978, Significance of the heterogeneity of parathyroid hormone, in: Endocrinology of Calcium Metabolism (R.V. Talmage, and D.H. Copp, eds.), pp. 308–340, Excerpta Medica, Amsterdam.
Boonstra, C.E., and Jackson, C.E., 1965, Hyperparathyroidism detected by routine serum calcium analysis: Prevalence in a clinic population, Ann. Intern. Med. 63: 468–474.
Vichayanrat, A., Avramides, A., Gardner, B., Wallach, S., and Carter, A.C., 1976, Primary hyperparathyroidism and breast cancer, Am. J. Med. 61: 136–139.
Dresner, M.K., and Lebovitz, H.E., 1978, Primary hyperparathyroidism in paraneoplastic hypercalcaemia, Lancet 1: 1004–1006.
Ackerman, N.B., and Winer, N., 1975, The differentiation of primary hyperparathyroidism from the hypercalcemia of malignancy, Ann. Surg. 181: 226–231.
Seyberth, H.W., Segre, G.V., Hamet, P., Sweetman, B.J., Potts, J.T., Jr., and Oates, J.A., 1976, Characterization of a group of patients with hypercalcemia of cancer who respond to treatment with prostaglandin synthesis inhibitors, Trans. Assoc. Am. Physicians 89: 92–104.
Broadus, A.E., Mahaffey, J.E., Bartter, F.C., and Neer, R.M., 1977, Nephrogenous cyclic adenosine monophosphate as a parathyroid function test, J. Clin. Invest. 60: 771–783.
Rude, R.K., Sharp, C.J., Jr., Oldham, S.D., and Singer, F.R., 1978, Plasma cyclic AMP (PcAMP) urinary cyclic AMP (UcAMP) and nephrogenic cyclic AMP (NcAMP) in the hypercalcemia of malignancy, Clin. Res. 26: 427A.
Robertson, R.P., Baylink, D.J., Metz, S.A., and Cummings, K.B., Plasma prostaglandin E in patients with cancer with and without hypercalcemia, J. Clin. Endocrinol. Metab. 43: 1330–1335.
Deftos, L.J., McMillan, T.J., Sartiano, G.P., Abuid, J., and Robinson, A.G., 1976, Simultaneous ectopic production of parathyroid hormone and calcitonin, Metabolism 25: 543–550.
Grajower, M., and Barzel, U.S., 1976, Ectopic hyperparathyroidism (pseudohyperparathyroidism) in esophageal malignancy, Am. J. Med. 61: 134–135.
Zidar, B.L., Shadduck, R.K., Winkelstein, A., Zeigler, Z., and Hawker, C.D., 1976, Acute myeloblastic leukemia and hypercalcemia: A case of probable ectopic parathyroid hormone production, N. Engl. J. Med. 295: 692–694.
Robins, N.I., Siegel, L.M., Hawker, C.D., and Magida, M.G., 1976, Hypercalcemia in metastatic intestinal leiomyosarcoma: A case of ectopic parathyroid hormone production, Conn. Med. 40: 609–611.
Editorial, 1976, Osteolytic metastases, Lancet 2: 1063–1064.
Bennett, A., McDonald, A.M., Stamford, I.F., Charlier, E.M., Simpson, J.S., and Zebro, T., 1977, Prostaglandins and breast cancer, Lancet 2: 624–626.
Seyberth, H.W., Raisz, L.G., and Oates, J.A., 1978, Prostaglandins and hypercalcemic states, Annu. Rev. Med. 29: 23–29.
Mundy, G.R., and Raisz, L.G., 1977, Big and little forms of osteoclast activating factor, J. Clin. Invest. 60: 122–128.
Marx, S.J., Zusman, R.M., and Umiker, W.O., 1977, Benign breast dysplasia causing hypercalcemia, J. Clin. Endocrinol. Metab. 45: 1049–1052.
Ellison, M., Woodhouse, D., Hillyard, C., Dowsett, M., Coombes, R.C., Gilby, E.D., Greenberg, P.B., and Neville, A.M., 1975, Immunoreactive calcitonin production by human lung carcinoma cells in culture, Br. J. Cancer 32: 373–379.
Hunt, N.H., Ellison, M., Underwood, J.C.E., and Martin, T.J., 1977, Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line, Br. J. Cancer 35: 777–784.
Deftos, L.J., Roos, B.A., Bronzert, D., and Parthemore, J.G., 1975, Immuno-chemical heterogeneity of calcitonin in plasma, J. Clin. Endocrinol. Metab. 40: 409–412.
Goltzman, D., and Tischler, A.S., 1978, Characterization of the immunochemical forms of calcitonin release by medullary thyroid carcinoma in tissue culture, J. Clin. Invest. 61: 449–458.
Coombes, R.C., Easty, G.C., Detre, S.I., Hillyard, C.J., Stevens, U., Girgis, S.I., Galante, L.S., Heywood, L., MacIntyre, I., and Neville, A.M., 1975, Secretion of immunoreactive calcitonin by human breast carcinomas, Br. Med. J. 4: 197–199.
Cadman, E.C., Lundberg, W.B., and Burtino, J.R., 1977, Hyperphosphatemia and hypocalcemia accompanying rapid cell lysis in a patient with Burkitt’s syndrome and Burkitt cell leukemia, Am. J. Med. 62: 283–290.
Drezner, M.K., and Feinglos, M.N., 1977, Osteomalacia due to 1α,25-dihydroxy-cholecalciferol deficiency: Association with a giant cell tumor of bone, J. Clin. Invest. 60: 1046–1053.
Pearse, A.G.E., and Polak, J.M., 1971, Neural crest origin of the endocrine polypeptide (APUD) cells of the gastrointestinal tract and pancreas, Gut 12: 783–788.
Chey, W.Y., and Gutierrez, J.G., 1978, The endocrine control of gastrointestinal function, Adv. Intern. Med. 23: 61–84.
Schein, P.S., DeLellis, R.A., Kahn, C.R., Gorden, P., and Kraft, A.R., 1973, Islet cell tumors: Current concepts and management, Ann. Intern. Med. 79: 239–257.
Verner, J.V., and Morrison, A.B., 1958, Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia, Am. J. Med. 25: 374–380.
Said, S.I., and Faloona, G.R., 1975, Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery diarrhea syndrome due to pancreatic, bronchogenic and other tumors, N. Engl. J. Med. 293: 155–160.
Said, S.I., 1975, Vasoactive intestinal peptide: Current status, in: Gastrointestinal Hormones (J.C. Thompson, ed.), pp 591–597, University of Texas Press, Austin.
Bryant, M.G., Polak, J.M., Modlin, I., Bloom, S.R., Albuquerque, R.H., and Pearse, A.G.E., 1976, Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance, Lancet 1: 991–993.
Kahn, C.R., Levy, A.G., Gardner, J.D., Miller, J.V., Gorden, P., and Schein, P.S., 1975, Pancreatic cholera: Beneficial effects of treatment with streptozocin, N. Engl. J. Med. 292: 941–945.
Gagel, R.F., Constanza, M.E., DeLellis, R.A., Norton, R.A., Bloom, S.R., Miller, H.H., Ucci, A., and Nathanson, L., 1976, Streptozocin-treated Verner-Morrison syndrome, Arch. Intern. Med. 136: 1429–1435.
Jaffe, B.M., Kopen, D.S., DeSchryver-Kecskemeti, K., Gingerich, R.L., and Greider, M., 1977, Indomethacin-responsive pancreatic cholera, N. Engl. J. Med. 297: 817–821.
Cryer, P.E., and Hill, G.J., II, 1976, Pancreatic islet cell carcinoma with hypercalcemia and hypergastrinemia: Response to streptozocin, Cancer 38: 2217–2221.
Floyd, J.C., Jr., Fajans, S.S., Pek, S., and Chance R.E., 1977, A newly recognized pancreatic polypeptide: Plasma levels in health and disease, Recent Prog. Horm. Res. 33: 519–570.
Bergstrom, B.H., Loo, S., Hirsch, H.J., Schutzengel, D., and Gabbay, K.H., 1977, Ultrastructural localization of pancreatic polypeptide in human pancreas, J. Clin. Endocrinol. Metab. 44: 795–798.
Polak, J.M., Adrian, T.E., Bryant, M.G., Bloom, S.R., Heitz, P., and Pearse, A.G.E., 1976, Pancreatic polypeptide in insulinomas, gastrinomas, vipomas and glucagonomas, Lancet 1: 328–330.
Larsson, L.I., Schwartz, T., Lundqvist, G., Chance, R.E., Sundler, F., Rehfeld, J.F., Grimelius, L., Fahrenkrug, J., Schaffalitzky de Muckadell, O., and Moon, N., 1976, Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors, Am. J. Pathol. 85: 675–684.
Bordi, C., Togni, R., Baetens, D., Ravazzola, M., Malaisse-Lagae, F., and Orci, L., 1977, Human islet cell tumors storing pancreatic polypeptide: A light and electron microscopic study, J. Clin. Endocrinol. Metab. 46: 215–219.
Heitz, P., Polak, J.M., Bloom, S.R., and Pearse, A.G.E., 1976, Identification of the D1 cell as a source of human pancreatic polypeptide (HPP), Gut 17: 755–758.
Marco, J., Hedo, J.A., and Vallanueva, M.L., 1978, Control of pancreatic polypeptide secretion by glucose in man, J. Clin. Endocrinol. Metab. 46: 140–145.
Polak, J.M., Bloom, S.R., Kuzio, M., and Brown, J.C., 1973, Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum, Gut 14: 284–288.
Brown, J.C., Dryburgh, J.R., Ross, S.A., and Dupre, J., 1975, Identification and actions of gastric inhibitory polypeptide, Recent Prog. Horm. Res. 31: 487–532.
Ganda, O.P., Weir, G.C., Soeldner, J.S., Legg, M.A., Chick, W.L., Patel, Y.C., Eberd, A.M., Gabbay, K.H., and Reichlin, S., 1977, “Somatostatinoma:” A somatostatin-containing tumor of the endocrine pancreas, N. Engl. J. Med. 296: 963–967.
Larsson, L.I., Holst, J.J., Kuhl, C., Lundqvist, G., Hirsch, M., Ingemansson, S., Lindkaer-Jensen, S., Rehfeld, J.F., and Schwartz, T.W., 1977, Pancreatic somatostatinoma: Clinical features and physiological implications, Lancet 1: 666–668.
Polak, J.M., Pearse, A.G.E., Grimelius, L., Bloom, S.R., and Arimura, A., 1975, Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells, Lancet 1: 1220–1222.
Unger, R.H., 1977, Somatostatinoma, N. Engl. J. Med. 296: 998–1000.
Kovacs, K., Horvath, E., Ezrin, S.C., Sepp, H., and Elkan, R., 1977, Immuno-reactive somatostatin in pancreatic islet-cell carcinoma accompanied by ectopic ACTH syndrome, Lancet 1: 1365–1366.
Mallinson, C.N., Bloom, S.R., Warin, A.P., Salmon, P.I., and Cox, B., 1974, Glucagonoma syndrome, Lancet 2: 1–5.
Valverde, I., Lemon, H.M., Kessinger, A., and Unger, R.H., 1976, Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma, J. Clin. Endocrinol. Metab. 42: 804–808.
Racant, L., Perrino, P.V., Bhathena, S.J., Danforth, D.N., Jr., and Levine, R.L., 1976, Plasma immunoreactive glucagon fractions in four cases of glucagonoma: Increased “large glucagon-immunoreactivity,” Diabetologia 12: 319–326.
Weir, G.C., Horton, E.S., Aoki, T.T., Slovik, D., Jaspan, J., and Rubenstein, A.H., 1977, Secretion by glucagonomas of a possible glucagon precursor, J. Clin. Invest. 59: 325–330.
Boden, G.N., and Owen, O.E., 1977, Familial hyperglucagonemia: An autosomal dominant disorder, N. Engl. J. Med. 286: 534–538.
Miyake, T., Rung, C.K.H., and Goldwasser, E., 1977, Purification of human erythropoietin, J. Biol. Chem. 252: 5558–5564.
Sherwood, J.B., and Goldwasser, E., 1978, Extraction of erythropoietin from normal kidney, Endocrinology 103: 866–870.
Sherwood, J.B., and Goldwasser, E., 1976, Erythropoietin production by human renal tumor cells in culture, Endocrinology 99: 504–510.
Day, R.P., Luetscher, J.A., and Zager, P.G., 1976, Big renin: Identification, chemical properties and clinical implications, Am. J. Cardiol. 37: 667–674.
Eagen, J.W., and Lewis, E.J., 1977, Glomerulopathies of neoplasia, Kidney Int. 11: 297–306.
Levinsky, R.J., Malleson, P.N., Barrett, T.M., and Soothill, J.S., 1978, Circulating immune complexes in steroid-responsive nephrotic syndrome, N. Engl. J. Med. 298: 126–129.
Schumacher, H.R., 1976, Articular manifestations of hypertrophic pulmonary osteoarthropathy in bronchogenic carcinoma, Arthritis Rheum. 19: 629–636.
Arnason, B.G.W., 1978, Paraneoplastic syndromes of muscle, nerve, and brain: Immunologic considerations, Clin. Immunol. Immunopathol. (in press).
Bender, A.N., Ringel, S.P., Engel, W.K., Daniels, M.P., and Vogel, Z., 1975, Myasthenia gravis: A serum factor blocking acetylcholine receptors of the human neuromuscular junction, Lancet 1: 607–609.
Richman, D.P., Patrick, J., and Arnason, B.G.W., 1976, Cellular immunity in myasthenia gravis, N. Engl. J. Med. 294: 694–698.
Barnes, B.E., 1976, Dermatomyositis and malignancy: A review of the literature, Ann. Intern. Med. 84: 68–76.
Arnason, B.G.W., 1975, Inflammatory polyradiculoneuropathies, in: Peripheral Neuropathy, Vol. 2 (P.J. Dyck, P.K. Thomas, and E.H. Lambert, eds.), pp. 1110–1148, W.B. Saunders, Philadelphia.
Lisak, R.P., Mitchell, M., Zweinam, B., Orrechio, E., and Asbury, A.K., 1975, Guillain-Barré syndrome and Hodgkin’s disease: Three cases with immunologic studies, Trans. Am. Neurol. Assoc. 100: 140–144.
Ishikawa, K., Engelhardt, J.K., Fujisawa, T., Okamoto, T., and Katsuki, H., 1977, A neuromuscular transmission block produced by a cancer tissue extract derived from a patient with the myasthenic syndrome, Neurology 27: 140–143.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sherwood, L.M. (1979). Ectopic Hormone Syndromes. In: Ingbar, S.H. (eds) Contemporary Endocrinology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-4857-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4857-4_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-4859-8
Online ISBN: 978-1-4757-4857-4
eBook Packages: Springer Book Archive